Decoy Therapeutics is trading 7% down at $3.60, extending recent weakness despite broader U.S. indexes trading higher on August 12, 2026, with the cause currently unclear.
- No confirmed company-specific announcement, earnings release, or other direct catalyst was identified.
- The latest listed release was the August 3, 2026 intellectual-property update, which does not explain the current move.
- Activity and volume data were unavailable.